University of Maryland Researcher Contributes to Study Presented at ASCO …
University of Maryland researcher contributes to study presented at ASCO …
Filed under: drug treatment centers in baltimore
Newswise — CHICAGO, June 2, 2013 — Adding bevacizumab (Avastin) to standard chemotherapy and radiation treatment does not improve survival for patients newly diagnosed with glioblastoma, a very aggressive form of brain cancer, researchers have …
Read more on Newswise (press release)
In Heroin's White Thrall
Filed under: drug treatment centers in baltimore
He drives around Baltimore, where he was, notionally, a graduate student in English at Johns Hopkins, from dope spot to a chain of abandoned rentals to dope spot to rehab center to dope spot, and he has conversations with such new friends as Funboy.
Read more on New Yorker (blog)
Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
Filed under: drug treatment centers in baltimore
The patent claiming tasimelteon as a new chemical entity extends through December 2022, assuming a 5-year extension to be granted under the Hatch-Waxman Act. Tasimelteon has been granted orphan drug designation for the treatment of Non-24 from both …
Read more on SYS-CON Media (press release)